Regulatory Affairs
Beyond the Headline: Are Irish Pharma Workers Truly the Highest Paid in Europe?
Recent reports suggest Irish pharma workers are the highest paid in Europe, but a deeper dive reveals a more complex reality. We analyze compensation packages, tax regimes, and cost of living across Europe’s top pharmaceutical hubs.
Regulatory Affairs
How to Build a Powerful Personal Brand in Pharma Without Sharing Proprietary Data
A complete step-by-step guide for pharmaceutical, biotech and life science professionals on building a credible, visible personal brand on LinkedIn - without ever crossing compliance lines or risking proprietary data exposure. Covers brand strategy, content pillars, storytelling frameworks, and the exact boundaries every pharma professional must respect.
Regulatory Affairs
How Most Favored Nation (MFN) Pricing Impacts Drug Development & Launch Planning
An expert analysis of the strategic shifts required in global drug development, indication sequencing, and launch timelines in response to proposed Most Favored Nation pricing and the Inflation Reduction Act.
Regulatory Affairs
Breckenridge Pharmaceutical Issues Major Recall for Duloxetine Capsules
Breckenridge Pharmaceutical has initiated a voluntary recall of hundreds of thousands of bottles of Duloxetine Delayed-Release Capsules due to the presence of nitrosamine impurities exceeding FDA limits.
Regulatory Affairs
Consumer Watchdog Launches Major Probe into Retail Pharmacy Sector Pricing
The Competition and Consumer Protection Commission (CCPC) has launched a comprehensive market study into Ireland's retail pharmacy sector, targeting opaque pricing practices and a lack of competition.
Regulatory Affairs
Landmark Agreements on Medicine Pricing and Supply Target 180-Day Turnaround by 2029
The Irish government signs major new Framework Agreements with MFI and IPHA, aiming to reduce patient wait times for innovative treatments to 180 days by 2029.
Regulatory Affairs
The GLP-1 Dilemma: Ireland’s Battle Over Blockbuster Weight-Loss Drugs
The Health Service Executive (HSE) is facing intense budgetary pressure as clinical demand for GLP-1 obesity medications skyrockets. We break down the restrictive funding, the "dreadful dichotomy" of access, and the surge in illegal online sales.
Regulatory Affairs
FDA 21 CFR Part 211 vs. EU GMP Annex 1: Key Differences
A comprehensive breakdown of the core differences between US FDA 21 CFR Part 211 and EU GMP Annex 1 for sterile and non-sterile pharmaceutical manufacturing.
Regulatory Affairs
CAPA vs. Root Cause Analysis (RCA) in Pharma
Understanding the critical distinction between Root Cause Analysis (RCA) and Corrective and Preventive Actions (CAPA) in pharmaceutical quality management systems.
Regulatory Affairs
AQL vs. RQL: Choosing the Right Sampling Plan
A technical guide to understanding Acceptable Quality Limit (AQL) versus Rejectable Quality Limit (RQL) in pharmaceutical statistical sampling and batch release.
Regulatory Affairs
Democratizing Pharma Compliance: How Priya LifeScience is Empowering Ireland's Biotech and Pharmaceutical Sectors with Free, Open-Source, and 100% Private Digital Utilities
Priya LifeScience is on a mission to democratize compliance, quality assurance, and documentation in Ireland's pharmaceutical and biotech sectors by providing 100% free, open-source, browser-native digital utilities.
Regulatory Affairs
Free GMP Document Stamp Tool for Irish Pharma: Apply APPROVED, DRAFT and CONTROLLED COPY to PDFs Without Cloud Upload
Irish pharma, MedTech and life science teams can now apply GMP-standard status stamps to pharmaceutical PDFs entirely in their browser - with zero file upload, zero server, and full compliance with GDPR Article 25, EU GMP Annex 1, FDA 21 CFR Part 11, and HPRA requirements.